{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:28:48Z","timestamp":1790180928199,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.patbio.2015.03.003","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T14:02:09Z","timestamp":1429020129000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis"],"prefix":"10.1016","volume":"63","author":[{"given":"T.","family":"Hua-Huy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.T.","family":"Dinh-Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.patbio.2015.03.003_bib0505","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-140-2-200401200-00013","article-title":"Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis","volume":"140","author":"Jimenez","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.patbio.2015.03.003_bib0510","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.patbio.2015.03.003_bib0515","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2015.03.003_bib0520","doi-asserted-by":"crossref","first-page":"A311","DOI":"10.1016\/j.autrev.2009.11.003","article-title":"Geoepidemiology of systemic sclerosis","volume":"9","author":"Ranque","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.patbio.2015.03.003_bib0525","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.patbio.2015.03.003_bib0530","first-page":"iii40","article-title":"Pulmonary complications: one of the most challenging complications of systemic sclerosis","volume":"48","author":"Wells","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.patbio.2015.03.003_bib0535","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1164\/arrd.1985.131.4.612","article-title":"Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis","volume":"131","author":"Rossi","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.patbio.2015.03.003_bib0540","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.patbio.2015.03.003_bib0545","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","article-title":"Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis","volume":"10","author":"Baraut","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.patbio.2015.03.003_bib0550","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00109-014-1190-x","article-title":"Molecular and cellular basis of scleroderma","volume":"92","author":"Eckes","year":"2014","journal-title":"J Mol Med (Berl)"},{"issue":"Suppl. 2","key":"10.1016\/j.patbio.2015.03.003_bib0555","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar2186","article-title":"How does endothelial cell injury start? The role of endothelin in systemic sclerosis","volume":"9","author":"Abraham","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.patbio.2015.03.003_bib0560","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/ard.2010.140657","article-title":"Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease","volume":"70","author":"Distler","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.patbio.2015.03.003_bib0565","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1165\/ajrcmb.11.4.7917311","article-title":"Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro","volume":"11","author":"Cambrey","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0570","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1523-1747.2001.01256.x","article-title":"Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1","volume":"116","author":"Shi-Wen","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0575","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1111\/j.1742-4658.2005.05016.x","article-title":"Signalling and regulation of collagen\u00a0I synthesis by ET-1 and TGF-beta1","volume":"272","author":"Horstmeyer","year":"2005","journal-title":"FEBS J"},{"key":"10.1016\/j.patbio.2015.03.003_bib0580","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1164\/ajrccm.156.2.9607123","article-title":"Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist","volume":"156","author":"Park","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.patbio.2015.03.003_bib0585","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/art.27466","article-title":"Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis","volume":"62","author":"Seibold","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0590","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1165\/ajrcmb.10.4.7510986","article-title":"Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor","volume":"10","author":"Ohba","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0595","doi-asserted-by":"crossref","first-page":"L334","DOI":"10.1152\/ajplung.00417.2002","article-title":"Contractile activity and smooth muscle alpha-actin organization in thrombin-induced human lung myofibroblasts","volume":"285","author":"Bogatkevich","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0600","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12016-009-8193-3","article-title":"The pathogenesis of systemic sclerosis revisited","volume":"40","author":"Geyer","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0605","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00002281-200311000-00015","article-title":"The role of chemokines in the pathogenesis of scleroderma","volume":"15","author":"Atamas","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0610","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L","article-title":"Production of type\u00a02 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis","volume":"42","author":"Atamas","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0615","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1172\/JCI115247","article-title":"Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences\u00a070-88 and 89-122","volume":"87","author":"Postlethwaite","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.patbio.2015.03.003_bib0620","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/CDLI.6.5.658-659.1999","article-title":"Interleukin-4 in systemic sclerosis: not just an increase","volume":"6","author":"Atamas","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0625","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1073\/pnas.93.15.7821","article-title":"Phenotypic and physiologic characterization of transgenic mice expressing interleukin\u00a04 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity","volume":"93","author":"Rankin","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.patbio.2015.03.003_bib0630","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1034\/j.1399-3003.1999.14b03.x","article-title":"Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies","volume":"14","author":"Majumdar","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.patbio.2015.03.003_bib0635","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000163933","article-title":"Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes\/macrophages","volume":"63","author":"Kr\u00e4ling","year":"1995","journal-title":"Pathobiology"},{"key":"10.1016\/j.patbio.2015.03.003_bib0640","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.patbio.2015.03.003_bib0645","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.4049\/jimmunol.168.6.3088","article-title":"Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation","volume":"168","author":"Zhang","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0650","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ni.3052","article-title":"The development and function of lung-resident macrophages and dendritic cells","volume":"16","author":"Kopf","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0655","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/ard.2009.121400","article-title":"Type\u00a0I interferon system activation and association with disease manifestations in systemic sclerosis","volume":"69","author":"Eloranta","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.patbio.2015.03.003_bib0660","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/art.23486","article-title":"Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase\u00a0I: association of higher interferon-alpha activity with lung fibrosis","volume":"58","author":"Kim","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0665","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2015.03.003_bib0670","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1172\/JCI7325","article-title":"An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response","volume":"104","author":"Chiaramonte","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.patbio.2015.03.003_bib0675","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.4049\/jimmunol.166.5.3432","article-title":"Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease","volume":"166","author":"Wangoo","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0680","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000098208","article-title":"Increased bleomycin-induced skin fibrosis in mice lacking the Th1-specific transcription factor T-bet","volume":"73","author":"Lakos","year":"2006","journal-title":"Pathobiology"},{"key":"10.1016\/j.patbio.2015.03.003_bib0685","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/rheumatology\/kei244","article-title":"Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients","volume":"45","author":"Tan","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.patbio.2015.03.003_bib0690","first-page":"1751","article-title":"Type\u00a02 helper T-cell predominance and high CD30 expression in systemic sclerosis","volume":"151","author":"Mavalia","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0695","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/art.37891","article-title":"Increased expression of endoplasmic reticulum stress and unfolded protein response genes in peripheral blood mononuclear cells from patients with limited cutaneous systemic sclerosis and pulmonary arterial hypertension","volume":"65","author":"Lenna","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0700","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar2766","article-title":"Bronchoalveolar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients","volume":"11","author":"Schmidt","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.patbio.2015.03.003_bib0705","first-page":"328","article-title":"Elevated serum levels of interleukin\u00a04 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis","volume":"24","author":"Hasegawa","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0710","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780350111","article-title":"Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma","volume":"35","author":"Needleman","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0715","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1568-9972(03)00005-3","article-title":"Systemic sclerosis: current views of its pathogenesis","volume":"2","author":"Derk","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.patbio.2015.03.003_bib0720","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1346-8138.2009.00763.x","article-title":"B\u00a0lymphocytes: shedding new light on the pathogenesis of systemic sclerosis","volume":"37","author":"Hasegawa","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0725","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/SMJ.0b013e31815838ce","article-title":"Systemic sclerosis and malignancy: a review of the literature","volume":"101","author":"Wooten","year":"2008","journal-title":"South Med J"},{"key":"10.1016\/j.patbio.2015.03.003_bib0730","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/art.27549","article-title":"Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase\u00a0I\/III antibodies","volume":"62","author":"Shah","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0735","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the auto-immune disease scleroderma with an immunologic response to cancer","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.patbio.2015.03.003_bib0740","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2015.03.003_bib0745","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.24381","article-title":"Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis","volume":"60","author":"Classen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0750","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.3899\/jrheum.091346","article-title":"Anti-endothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis","volume":"37","author":"Del Papa","year":"2010","journal-title":"J Rheumatol"},{"issue":"11 Suppl.","key":"10.1016\/j.patbio.2015.03.003_bib0755","first-page":"858","article-title":"Antifibroblast antibodies in systemic sclerosis","volume":"4","author":"Ronda","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.patbio.2015.03.003_bib0760","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.4049\/jimmunol.175.7.4555","article-title":"Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-\u03b2 pathway to recapitulate the \u201cscleroderma phenotype\u201d","volume":"175","author":"Zhou","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0765","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/art.22847","article-title":"B\u00a0cell infiltration in systemic sclerosis-associated interstitial lung disease","volume":"56","author":"Lafyatis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0770","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.autrev.2014.07.003","article-title":"Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity","volume":"13","author":"Lanteri","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.patbio.2015.03.003_bib0775","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/art.20274","article-title":"Altered blood\u00a0B lymphocyte homeostasis in systemic sclerosis: expanded naive B\u00a0cells and diminished but activated memory B\u00a0cells","volume":"50","author":"Sato","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0780","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2353\/ajpath.2006.060205","article-title":"B-lymphocyte depletion reduces skin fibrosis and auto-immunity in the tight-skin mouse model for systemic sclerosis","volume":"169","author":"Hasegawa","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0785","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis\u00a0B lymphocytes","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0790","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1172\/JCI107827","article-title":"Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast","volume":"54","author":"LeRoy","year":"1974","journal-title":"J Clin Invest"},{"key":"10.1016\/j.patbio.2015.03.003_bib0795","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1523-1747.1998.00073.x","article-title":"Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype","volume":"110","author":"Kawakami","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0800","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1084\/jem.175.5.1227","article-title":"Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts","volume":"175","author":"Yamakage","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.patbio.2015.03.003_bib0805","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jdermsci.2007.05.014","article-title":"Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis","volume":"49","author":"Ihn","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.patbio.2015.03.003_bib0810","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/1529-0131(200106)44:6<1382::AID-ART231>3.0.CO;2-T","article-title":"Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein\u00a01 expression","volume":"44","author":"Galindo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0815","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8","article-title":"Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis","volume":"43","author":"Jelaska","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0820","doi-asserted-by":"crossref","first-page":"R1113","DOI":"10.1186\/ar1790","article-title":"Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis","volume":"7","author":"Rajkumar","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.patbio.2015.03.003_bib0825","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/art.22047","article-title":"Differential expression of stromal cell-derived factor\u00a01 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implications","volume":"54","author":"Cipriani","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0830","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1172\/JCI200420997","article-title":"Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis","volume":"114","author":"Phillips","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.patbio.2015.03.003_bib0835","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.humpath.2009.02.020","article-title":"Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition","volume":"40","author":"Guarino","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0840","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2014.53","article-title":"Fibrosis \u2013 a lethal component of systemic sclerosis","volume":"10","author":"Ho","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0845","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/art.10413","article-title":"Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis","volume":"46","author":"Varga","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0850","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/1523-1747.ep12313452","article-title":"Growth regulation in scleroderma fibroblasts: increased response to transforming growth factor-beta\u00a01","volume":"105","author":"Kikuchi","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0855","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/excr.2000.4972","article-title":"Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis","volume":"259","author":"Shi-wen","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.patbio.2015.03.003_bib0860","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/1529-0131(200102)44:2<474::AID-ANR67>3.0.CO;2-#","article-title":"Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta-receptors","volume":"44","author":"Ihn","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0865","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/rheumatology\/kei124","article-title":"Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts","volume":"45","author":"Ihn","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.patbio.2015.03.003_bib0870","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/art.11157","article-title":"Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts","volume":"48","author":"Mori","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0875","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1523-1747.2003.12308.x","article-title":"Sustained activation of fibroblast transforming growth factor-beta\/Smad signaling in a murine model of scleroderma","volume":"121","author":"Takagawa","year":"2003","journal-title":"J Invest Dermatol"},{"issue":"Suppl. 5","key":"10.1016\/j.patbio.2015.03.003_bib0880","doi-asserted-by":"crossref","first-page":"v2","DOI":"10.1093\/rheumatology\/ken265","article-title":"Role of PDGF in fibrotic diseases and systemic sclerosis","volume":"47","author":"Trojanowska","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.patbio.2015.03.003_bib0885","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncprheum0346","article-title":"Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis","volume":"2","author":"Sakkas","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0890","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000094242","article-title":"Chemokines and chemokine receptors in scleroderma","volume":"140","author":"Yamamoto","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0895","doi-asserted-by":"crossref","first-page":"17779","DOI":"10.1074\/jbc.271.30.17779","article-title":"Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors","volume":"271","author":"Gharaee-Kermani","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.patbio.2015.03.003_bib0900","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.4049\/jimmunol.164.12.6174","article-title":"Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop","volume":"164","author":"Yamamoto","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0905","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/1521-4141(2001010)31:10<2936::AID-IMMU2936>3.0.CO;2-0","article-title":"High expression and auto-induction of monocytes chemoattractant protein-1 in scleroderma fibroblasts","volume":"31","author":"Yamamoto","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0910","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/art.21396","article-title":"Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation","volume":"52","author":"Carulli","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0915","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/art.30254","article-title":"Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis","volume":"63","author":"Dees","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0920","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/annrheumdis-2013-203995","article-title":"Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling","volume":"73","author":"Distler","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.patbio.2015.03.003_bib0925","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s13075-014-0411-6","article-title":"Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts","volume":"16","author":"Tsou","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.patbio.2015.03.003_bib0930","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1465-9921-14-80","article-title":"Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease","volume":"14","author":"Lindahl","year":"2013","journal-title":"Respir Res"},{"key":"10.1016\/j.patbio.2015.03.003_bib0935","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/ars.2007.1942","article-title":"Oxidant-antioxidant imbalance as a potential contributor to the progression of human pulmonary fibrosis","volume":"10","author":"Kinnula","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.patbio.2015.03.003_bib0940","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1","article-title":"Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway","volume":"44","author":"Sambo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0945","doi-asserted-by":"crossref","first-page":"36474","DOI":"10.1074\/jbc.M502851200","article-title":"Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1\/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts","volume":"280","author":"Svegliati","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.patbio.2015.03.003_bib0950","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1002\/art.30470","article-title":"The specific free radical scavenger edaravone suppresses fibrosis in the bleomycin-induced and tight skin mouse models of systemic sclerosis","volume":"63","author":"Yoshizaki","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0955","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","article-title":"Selective oxidation of DNA topoisomerase\u00a01 induces systemic sclerosis in the mouse","volume":"182","author":"Servettaz","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0960","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2353\/ajpath.2010.090763","article-title":"Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis","volume":"177","author":"Servettaz","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0965","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1002\/art.27626","article-title":"Targeting ADAM-17\/notch signaling abrogates the development of systemic sclerosis in a murine model","volume":"62","author":"Kavian","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0970","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/art.34354","article-title":"Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor \u03b2 in the skin of mice with scleroderma-like features and prevents the development of the disease","volume":"64","author":"Kavian","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0975","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/art.37873","article-title":"Amelioration of systemic fibrosis in mice by angiotensin\u00a0II receptor blockade","volume":"65","author":"Marut","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0980","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/art.34534","article-title":"Reactive oxygen species-mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis","volume":"64","author":"Kavian","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.patbio.2015.03.003_bib0985","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/BOR.0b013e3283310d57","article-title":"Disease-modifying treatment in systemic sclerosis: current status","volume":"21","author":"Quillinan","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.patbio.2015.03.003_bib0990","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase\u00a02 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2015.03.003_bib0995","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.patbio.2015.03.003_bib1000","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrrheum.2012.191","article-title":"Systemic sclerosis-challenges for clinical practice","volume":"9","author":"McMahan","year":"2013","journal-title":"Nat Rev Rheumatol"}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811415000206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811415000206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T11:29:01Z","timestamp":1717846141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0369811415000206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0369811415000206"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2015.03.003","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Pathologie Biologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.patbio.2015.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}